PMC 12446177
L-glutamine, an amino acid, may help support intestinal lining health
The Phase 3 FLOW trial evaluated Ozempic in patients with T2DM and CKD
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Image Credit: Pingpoy / Shutterstock Vasoplegic syndrome Vasoplegic syndrome refers to vasodilative shock that can present as severe hypotension, tachycardia, altered cardiac output, and/or reduced pulmonary pressure
The advantages of this approach are significant, including prolonged retention duration within the system, safer administration, enhanced treatment effect, and improved metabolism of substances, all contributing to its appeal in medical applications [81]